Exagen (XGN) P/E (2019 - 2026)
Exagen (XGN) P/E from Sep 30, 2019 to Jul 21, 2026. The TTM Exagen (XGN) P/E is -5.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Exagen (XGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.49 | -16.08% |
| 2025 | -6.54 | +38.02% |
| 2024 | -4.74 | +274.01% |
| 2023 | -1.27 | +30.69% |
| 2022 | -0.97 | -87.65% |
| 2021 | -7.85 | -21.52% |
| 2020 | -10.00 | -79.46% |
| 2019 | -48.71 | N/A |
Comparison Exagen (XGN) P/E with competitors
Exagen (XGN) P/E is -5.49.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -119.10% |
| MBAI | CheckCap Ltd | 1.71 | -131.20% |
| FONR | Fonar Corp | 15.48 | -381.99% |
| QGEN | Qiagen NV | 20.03 | -464.92% |
| DGX | Quest Diagnostics Inc | 22.47 | -509.44% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -534.90% |
| IQV | IQVIA Holdings Inc | 25.28 | -560.62% |
| A | Agilent Technologies Inc | 26.96 | -591.14% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -674.42% |
| MTD | Mettler-Toledo International Inc | 32.45 | -691.20% |
| MEDP | Medpace Holdings Inc | 32.55 | -693.02% |
| DHR | Danaher Corp | 38.55 | -802.39% |
| IDXX | Idexx Laboratories Inc | 40.58 | -839.23% |
| ILMN | Illumina Inc | 44.12 | -903.80% |
| RVTY | Revvity Inc | 52.68 | -1059.78% |
| VCYT | Veracyte Inc | 53.71 | -1078.56% |
| ICLR | Icon Plc | 57.45 | -1146.69% |
| SHC | Sotera Health Company | 74.08 | -1449.72% |
| WAT | Waters Corp | 102.79 | -1972.63% |